Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Zelasudil by Redx Pharma for Metabolic Dysfunction-Associated Steatohepatitis (MASH): Likelihood of Approval
Zelasudil is under clinical development by Redx Pharma and currently in Phase I for Metabolic Dysfunction-Associated Steatohepatitis (MASH). According to...
Data Insights
Zelasudil by Redx Pharma for Idiopathic Pulmonary Fibrosis: Likelihood of Approval
Zelasudil is under clinical development by Redx Pharma and currently in Phase II for Idiopathic Pulmonary Fibrosis. According to GlobalData,...